ISIN | CH0378648601 |
---|---|
Valor Number | 37864860 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Equity Fund Responsible Global Future Trends CT CHF |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | The Fund focuses on investments worldwide in companies in the health care sector: pharmaceuticals, medical technology, health care providers and biotechnology. The equity portfolio has a global approach. The benchmark is the MSCI World Health Care Index in CHF. The Fund invests primarily in listed and unlisted equity securities and other investments permitted by the Fund's regulations. This actively managed Fund is an ideal addition both to individual securities and index products, making it equally suitable for private and institutional investors. |
Peculiarities |
Current Price * | 153.98 CHF | 21.11.2024 |
---|---|---|
Previous Price * | 153.17 CHF | 20.11.2024 |
52 Week High * | 155.61 CHF | 11.11.2024 |
52 Week Low * | 129.27 CHF | 05.01.2024 |
NAV * | 153.98 CHF | 21.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 79,218,962 | |
Unit/Share Assets *** | 22,625,464 | |
Trading Information SIX |
YTD Performance | +17.01% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
1 month | +1.31% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | +5.28% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | +1.65% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +18.01% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +21.11% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | +0.27% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +32.74% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Equity Participation Rate in % | 89.58 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Apple Inc | 4.81% | |
---|---|---|
Microsoft Corp | 4.28% | |
NVIDIA Corp | 3.65% | |
Alphabet Inc Class A | 2.78% | |
Amazon.com Inc | 2.56% | |
Roche Holding AG | 1.91% | |
Electronic Arts Inc | 1.72% | |
Match Group Inc | 1.70% | |
Virtu Financial Inc Class A | 1.69% | |
Royalty Pharma PLC Class A | 1.59% | |
Last data update | 31.10.2024 |
TER | 0.91% |
---|---|
TER date | 29.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.30% |
Ongoing Charges *** | 0.91% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |